Results 131 to 140 of about 7,182,421 (220)

Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation. [PDF]

Clin Exp Metastasis
Spartz A, Schmidt S, Mohamed F, Troness B, Lange CA, El-Ashry D.   +5 more
europepmc   +1 more source

Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock. [PDF]

Eur Heart J Acute Cardiovasc Care, 2022
Hongisto M, Lassus J, Tarvasmäki T, Sans-Roselló J, Tolppanen H, Kataja A, Jäntti T, Sabell T, Banaszewski M, Silva-Cardoso J, Parissis J, Jurkko R, Spinar J, Castrén M, Mebazaa A, Masip J, Harjola VP, CardShock Study Investigators and the GREAT Network.   +17 more
europepmc   +1 more source

High serum urokinase-type plasminogen activator receptor correlates with sepsis-induced cardiomyopathy in sepsis patients. [PDF]

Front Med (Lausanne)
He J, Wu T, Wu G, Huang Y, Yin X, Zhang M, Fang B, Guo L.   +7 more
europepmc   +1 more source

Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects. [PDF]

BMC Oral Health, 2022
El-Patal MA, Khalil MA, Shipl W, Barakat I, Youssef EMI, El Attar S, Fathi A, Abdallah AA.   +7 more
europepmc   +1 more source

Generation of a selective urokinase-type plasminogen activator (uPA) inhibitor based on a bicyclic peptide

, 2011
A conjugate which is capable of specific binding to and inhibition of urokinase-type plasminogen activator (UPA) comprising a polypeptide molecule and a scaffold molecule, wherein said polypeptide molecule is attached to said scaffold molecule by at ...
Christian Heinis, Alessandro Angelini, Greg Winter   +2 more
core  

The relationship between the urokinase-type plasminogen activator gene Pro141Leu polymorphism and patients with prostate cancer. [PDF]

Rev Assoc Med Bras (1992)
Gülüm C, Eroğlu P, Tanrıverdi R, Bozlu M.   +3 more
europepmc   +1 more source

Prognostic value of soluble urokinase-type plasminogen activator receptor in coronary artery disease: A meta-analysis. [PDF]

Eur J Clin Invest, 2022
Li Y, Ding Y, Zhao Y, Gui Y, Shen Y, Xiang Q.   +5 more
europepmc   +1 more source

The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies. [PDF]

Cancers (Basel)
Iftikhar A, Mahmood N, Rabbani SA.
europepmc   +1 more source

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women. [PDF]

J Clin Med, 2023
Wlazeł RN, Guligowska A, Chrząstek Z, Kostka T, Jegier A, Szadkowska I.   +5 more
europepmc   +1 more source

DDAVP induces systematic release of urokinase-type plasminogen activator

, 1989
The desamino-d-arginine vasopressin (DDAVP) induced enhancement of endogenous fibrinolysis is generally attributed to the release of tissue-type plasminogen activator (t-PA) from the vessel wall.
Cate, J.W. ten, Dooijewaard, G., Agnelli, G., Levi, M., Brommer, E.J., Sturk. A.   +5 more
core